Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by D. E. Zhang
The Chimeric Genes AML1/MDS1 and AML1/EAP Inhibit AML1B Activation at the CSF1R Promoter, but Only AML1/MDS1 Has Tumor-Promoter Properties.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Related publications
Targeted Degradation of the AML1/MDS1/EVI1 Oncoprotein by Arsenic Trioxide
Cancer Research
Cancer Research
Oncology
AML1 (Acute Myeloid Leukemia 1)
Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer Research
Oncology
Genetics
Hematology
Three Distinct Domains in TEL-AML1 Are Required for Transcriptional Repression of the IL-3 Promoter
Oncogene
Cancer Research
Genetics
Molecular Biology
AML1 (CBFα2) Cooperates With B Cell-Specific Activating Protein (BSAP/PAX5) in Activation of the B Cell-specificBLKGene Promoter
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
CCAAT Enhancer-Binding Protein (C/Ebp) and AML1 (CBF Alpha2) Synergistically Activate the Macrophage Colony-Stimulating Factor Receptor Promoter.
Molecular and Cellular Biology
Cell Biology
Molecular Biology
Epigenetic Consequences of AML1-ETO Action at the Human C-FMS Locus
EMBO Journal
Immunology
Molecular Biology
Biochemistry
Microbiology
Neuroscience
Medicine
Genetics
Significance of the TEL-AML1 Fusion Gene in Childhood AML
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
ETO, but Not Leukemogenic Fusion Protein AML1/ETO, Augments RBP-J /SHARP-Mediated Repression of Notch Target Genes
Molecular and Cellular Biology
Cell Biology
Molecular Biology
Acute Myeloid Leukemia With T(3;21)(q26.2;q22) Developing Following Low‑dose Methotrexate Therapy for Rheumatoid Arthritis and Expressing Two AML1/MDS1/EVI1 Fusion Proteins: A Case Report
Oncology Letters
Cancer Research
Oncology
